Legal notice: This tracker is general information about U.S. federal hemp law, not legal advice. Federal, state, local, product-specific, and agency rules can differ. Check the linked official records and qualified counsel before making compliance, inventory, sales, shipping, or investment decisions.
This tracker separates enacted law from future effective dates and proposals that are not law. H.R. 6500 enactment, citations, and Section 781 transition dates were rechecked September 29, 2026. Pending-bill statuses were last reviewed September 11, 2026. The FDA implementation and court-activity watch sections were last checked September 5, 2026. Each major status links to a primary government record.
Status at a Glance
| Issue | Enacted-law status checked September 29, 2026 | Date | Primary source |
|---|---|---|---|
| H.R. 6500 | Enacted. The President signed the Continuing Appropriations and Extensions Act, 2027 (Public Law 119-103). Its Section 2019 creates a temporary limit on how broadly the 2025 Section 781 hemp amendments apply during the transition window. | Signed September 2, 2026 | White House signing notice · GovInfo enrolled text · Senate public-law listing: P.L. 119-103 |
| Existing federal hemp framework before the transition | Current. The 2025 Section 781 amendments were enacted with a 365-day delayed effective date. H.R. 6500 changes the scope during the transition rather than simply deleting the November 12 date. | Through November 11, 2026 | U.S. Code preliminary text and statutory notes |
| Products containing cannabinoids not capable of being naturally produced by Cannabis sativa L. | Enacted / scheduled. Section 2019 says that until December 11 the Section 781 amendments apply only to the two named intermediate/final-product clauses concerning cannabinoids not capable of being naturally produced by the plant. | November 12, 2026 | H.R. 6500 enrolled text, Section 2019 · Public Law 119-37, Section 781 |
| Most remaining Section 781 hemp-definition changes | Enacted / scheduled. The temporary Section 2019 limitation ends December 11. The remaining 2025 changes include the broader total-THC framework and final-product per-container exclusion. | December 11, 2026 | H.R. 6500 enrolled text · Public Law 119-37 |
| State hemp rules | Separate. H.R. 6500 does not make one federal date a complete answer for every state or product. | Varies | CBD & Hemp Laws |
Why November 12 and December 11 Are Different
Public Law 119-37 originally set the Section 781 definition changes to take effect 365 days after November 12, 2025. H.R. 6500’s Section 2019 does not simply replace that date with December 11. Instead, it says that until December 11, 2026, the Section 781 amendments apply only to two specified clauses involving intermediate and final hemp-derived cannabinoid products containing cannabinoids that are not capable of being naturally produced by a Cannabis sativa L. plant.
That creates a 29-day transition. The narrow named exclusions remain tied to November 12. Most of the broader Section 781 changes are held back until the temporary limitation ends on December 11.
For a fuller explanation, read Federal Hemp Ban Delay Is Law: What H.R. 6500 Changes.
Bills That Could Still Change the Framework
| Bill | What it would do | Current status | Official source |
|---|---|---|---|
| H.R. 6209 American Hemp Protection Act of 2025 |
Would repeal Section 781. | Introduced, not enacted. Introduced November 20, 2025 and referred to the House Agriculture Committee; later referred to a subcommittee. It does not change current law unless Congress passes it and it becomes law. | GovInfo H.R. 6209 |
| H.R. 7024 Hemp Planting Predictability Act |
Would replace the Section 781 implementation period with a three-year delay. | Introduced, not enacted. Introduced January 13, 2026 and referred to House Agriculture. The proposal itself does not change an effective date. | GovInfo H.R. 7024 |
| H.R. 9830 Lawful Hemp Protection Act |
Would repeal Section 781 and establish a different federal framework for hemp-derived cannabinoid products. | Introduced, not enacted. Introduced July 22, 2026 and referred to Ways and Means, Energy and Commerce, Agriculture, and Transportation and Infrastructure. | GovInfo H.R. 9830 |
FDA Implementation Watch
Section 781 directed FDA, in consultation with other federal agencies, to publish within 90 days of enactment lists addressing cannabinoids capable of being naturally produced by cannabis, naturally occurring THC-class cannabinoids, other cannabinoids with similar effects, and more detail about the statutory term container.
Status on September 5, 2026: Not located in CBDCafe’s current FDA search. Congressional Research Service reporting in August likewise said the required publication had not yet appeared. CBDCafe is therefore treating this implementation item as Unknown / pending, not as though a missing agency publication has supplied an answer.
Read the statutory publication requirement · FDA cannabis-derived product information
Court Activity Watch
No direct federal court ruling changing Section 781’s federal effective-date framework was identified in CBDCafe’s September 5 check. Hemp litigation is active in the states, including challenges to state restrictions, but a state-law case does not by itself change the federal dates shown above.
This field will change only when a court record directly affects the federal rule or when a relevant federal case materially changes how the statute should be described.
How to Use This Tracker
- Check whether the item is current law, an enacted future change, or only a proposal.
- Check the effective date rather than relying on a headline saying a law was “delayed.”
- Open the linked primary source before making a product or business decision.
- Check the rules in the state and locality that apply to the product or transaction.
- Use qualified legal counsel for classification or compliance decisions.
Related resources: CBD Legal Status: Federal Guide · State CBD Law Database · Federal and State CBD Update Log · H.R. 6500 Hemp Delay Guide
H.R. 6500 enactment, citations, and transition dates rechecked: September 29, 2026. Pending-bill statuses last reviewed: September 11, 2026. FDA implementation and court-activity watch last checked: September 5, 2026.